Skip to main content

Denicolò S, Perco P, Thöni S, Mayer G; Journal of Diabetes and its Complications.;35 . Epub ahead of print July 1, 2021. DOI: 10.1016/j.jdiacomp.2021.107931.


Cardiovascular and renal complications are a major burden for individuals with type 2 diabetes mellitus (T2DM). Besides lifestyle interventions, current guidelines recommend combination drug therapy to prevent or delay the incidence and progression of comorbidities. However, non-adherence to pharmacotherapy is common in chronic conditions such as T2DM and a barrier to successful disease management. Numerous studies have associated medication non-adherence with worse outcome as well as higher health care costs. This narrative review provides (i) an overview on adherence measures used within and outside research settings, (ii) an estimate on the prevalence of non-adherence to antidiabetic and cardiovascular drugs in T2DM, and (iii) specifically focuses on the association of non-adherence to these drugs with renal and cardiovascular outcomes.

EU Flag DC-ren | Medical University Innsbruck

DC-ren has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848011.